Clinical Trial

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Study acronym: CLARITY
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greater than 50% re-narrowing of the treated artery) in adult patients who have CLTI and are undergoing percutaneous revascularization.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-16.
Status change: Not Yet Recruiting → Recruiting 2026-06-04
Trial Details
NCT Number NCT06979284
Lead Sponsor Hamilton Health Sciences Corporation
Conditions Peripheral Arterial Disease(PAD), Chronic Limb Threatening Ischemia, Intravascular Ultrasound, Major Adverse Limb Events, Restenosis
Enrollment 772 participants
Start Date 2025-12-05
Primary Completion 2030-07 (estimated)
Study Completion 2030-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-08